An updated patent review of Nrf2 activators (2020-present)
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2023.2178299
Abstract: ABSTRACT Introduction The nuclear factor erythroid 2-related factor 2 (Nrf2) is a pivotal transcription factor that controls the expression of numerous cytoprotective genes and regulates cellular defense system against oxidative insults. Thus, activating the Nrf2… read more here.
Keywords: updated patent; patent review; nrf2 activators; activators 2020 ... See more keywords